Antimicrobial susceptibility by Etest of Bartonella henselae isolated from cats and human in Japan

被引:10
作者
Tsuneoka, Hidehiro [1 ]
Yanagihara, Masashi [1 ]
Nojima, Junzo [1 ]
Ichihara, Kiyoshi [1 ]
机构
[1] Yamaguchi Univ, Grad Sch Med, Dept Clin Lab Sci, Yamaguchi 7558505, Japan
关键词
Bartonella henselae; MICs; Cat-scratch disease; Etest; SCRATCH DISEASE; PCR;
D O I
10.1007/s10156-010-0081-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Bartonella henselae, a small fastidious Gram-negative bacillus, is the causative agent of cat-scratch disease (CSD). Because of difficulty in isolating the organism, there has been no report on its antibiotic susceptibility in Japan. We determined the minimal inhibitory concentrations (MICs) of eight antimicrobial agents against 32 isolates of B. henselae (31 from cats and one from a human in Japan) by the Etest method. MICs of all 32 isolates were < 0.016 mu g/ml for minocycline and ranged from a parts per thousand currency sign0.016 to 0.064 mu g/ml for erythromycin, clarithromycin, azithromycin, ceftriaxone, and amoxicillin. MICs ranges of ciprofloxacin and gentamicin were from 0.064 to 0.25 mu g/ml and from 0.5 to 3 mu g/ml, respectively. All isolated strains showed high susceptibility to minocycline and macrolides antibiotics, which are currently used in the primary treatment of CSD in Japan. Although in vitro result of B. henselae susceptibility testing may not necessarily correlate with clinical response, these data are relevant in the choice of drugs for CSD treatment.
引用
收藏
页码:446 / 448
页数:3
相关论文
共 12 条
[1]   DETECTION OF ROCHALIMAEA-HENSELAE DNA IN SPECIMENS FROM CAT-SCRATCH DISEASE PATIENTS BY PCR [J].
ANDERSON, B ;
SIMS, K ;
REGNERY, R ;
ROBINSON, L ;
SCHMIDT, MJ ;
GORAL, S ;
HAGER, C ;
EDWARDS, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (04) :942-948
[2]   Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease [J].
Bass, JW ;
Freitas, BC ;
Freitas, AD ;
Freitas, D ;
Sisler, CL ;
Chan, DS ;
Vincent, JM ;
Person, DA ;
Claybaugh, JR ;
Wittler, RR ;
Weisse, ME ;
Regnery, RL ;
Slater, LN .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (06) :447-452
[3]   Molecular characterization of resistance to macrolides in Bartonella henselae [J].
Biswas, Silpak ;
Raoult, Didier ;
Rolain, Jean-Marc .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) :3192-3193
[4]   In vitro susceptibility of Bartonella species to 17 antimicrobial compounds:: comparison of Etest and agar dilution [J].
Doerbecker, Christina ;
Sander, Anna ;
Oberle, Karin ;
Schulin-Casonato, Tanja .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (04) :784-788
[5]   Rapid identification and differentiation of Bartonella species using a single-step PCR assay [J].
Jensen, WA ;
Fall, MZ ;
Rooney, J ;
Kordick, DL ;
Breitschwerdt, EB .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (05) :1717-1722
[6]   ANTIBIOTIC-THERAPY FOR CAT-SCRATCH DISEASE - CLINICAL-STUDY OF THERAPEUTIC OUTCOME IN 268 PATIENTS AND A REVIEW OF THE LITERATURE [J].
MARGILETH, AM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (06) :474-478
[7]   MICS OF 28 ANTIBIOTIC COMPOUNDS FOR 14 BARTONELLA (FORMERLY ROCHALIMAEA) ISOLATES [J].
MAURIN, M ;
GASQUET, S ;
DUCCO, C ;
RAOULT, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2387-2391
[8]   Current knowledge of Bartonella species [J].
Maurin, M ;
Birtles, R ;
Raoult, D .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (07) :487-506
[9]  
Murakami Kyoko, 2002, Journal of Infection and Chemotherapy, V8, P349, DOI 10.1007/s10156-002-0194-6
[10]   Antimicrobial susceptibility of Bartonella henselae using Etest methodology [J].
Pendle, S ;
Ginn, A ;
Iredell, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) :761-763